New Med to Manage Tourette Syndrome Shows Promise in Phase III Clinical Trial

Emalex Biosciences to use data from research led by Cincinnati Children's to seek FDA approval for ecopipam, the first drug designed to treat children with motor and vocal tics CINCINNATI, May 26, 2026 /PRNewswire/ -- Continued use of a drug called ecopipam can cut the risk of relapse in...